The FDA found concerns at a factory in India that makes generic drugs for U.S. patients including one drug that was manufactured at the facility and has been linked to at least eight deaths, ProPublica reported March 20. The agency…
Pharmacy
Richmond-based Virginia Commonwealth University is launching an accelerated program during the fall that allows students to earn both a Bachelor of Science in pharmaceutical sciences and a Doctor of Pharmacy degree in seven years instead of eight. The program aims…
Effective March 20, Optum Rx will increase reimbursements to pharmacies for brand-name drugs and cut them for generics. Optum Rx said the new pharmacy payment models are in response to price increases set by brand name drug manufacturers. “With this…
Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share their greatest lesson from 2024. The 6 executives featured in this article are all speaking at the Becker’s Healthcare Spring Chief Pharmacy Officer Summit, April 30…
Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share their biggest lesson from the previous year. The 12 executives featured in this article are all speaking at the Becker’s Healthcare Fall Chief Pharmacy Officer Summit,…
Advertisement
Health systems can cut costs and enhance patient care by evaluating their 340B drug purchases, according to a March 19 report from Pharmacy Practice News. Samuel Lewis, PharmD, pharmacy business manager at Indianapolis-based Eskenazi Health, said a recent routine 340B…
Optum Rx, the pharmacy benefit manager under UnitedHealth Group, is set to eliminate prior authorization requirements for approximately 80 prescription drugs in an effort to simplify access to medications for patients with chronic conditions. The changes are expected to reduce…
Cambridge, Mass.-based Sarepta Therapeutics reported the first known death from its Duchenne muscular dystrophy gene therapy treatment. The patient was a young man who suffered acute liver failure after being treated with Elevidys, according to a March 18 company news…
Mark Cuban Cost Plus Drug Co. is disrupting the traditional hospital pharmaceutical purchasing model, according to leaders at ScionHealth, which partnered with Cost Plus Drugs nearly a year ago. In May, Louisville, Ky.-based ScionHealth became the second health system to…
Biotech company Valo Health and AI healthcare firm nference have entered into a multi-year partnership to leverage AI and patient data in drug discovery and development. The collaboration will integrate nference’s AI platform, which processes de-identified data from top academic…